Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
560 1st Ave. TH4-12A
New York, NY 10016Phone+1 212-263-2269- Is this information wrong?
Summary
- Dr. Cheng Z. Liu is a pathologist in New York, NY at NYU Langone Hospitals. He received his medical degree from Hubei Medical University and has been in practice 25 years. He specializes in anatomic pathology and clinical pathology.
Education & Training
- The MetroHealth System/Case Western Reserve UniversityResidency, Pathology-Anatomic and Clinical, 1996 - 2000
- Northwestern university Ph.D., Cell and Molecular Pathology , 1990 - 1995
- Hubei Medical UniversityClass of 1982
Certifications & Licensure
- NY State Medical License 2014 - 2025
- WI State Medical License 2013 - 2025
- OK State Medical License 2001 - 2024
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 3 citationsMolecular Profiles of Noninvasive, Minimally Invasive, and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features.Tamar C Brandler, Fang Zhou, Cheng Z Liu, Antonio Serrano, Wei Sun, Yuri E Nikiforov, Steven P Hodak> ;Thyroid. 2023 Jun 1
- Case Report: Giant Thyroid Angiolipoma-Challenging Clinical Diagnosis and Novel Genetic Alterations.Reid Wilkins, Elcin Zan, Olga Leonardi, Kepal N Patel, Adam S Jacobson, George Jour, Cheng Z Liu, Fang Zhou> ;Head and Neck Pathology. 2023 Mar 1
- Myopericytoma of the Parotid and Molecular Profiling: Report of a Rare Case and Review of the Literature.Nicholas J Roig, Michelle Wu, Osvaldo Hernandez, Cheng Z Liu, Tamar C Brandler> ;International Journal of Surgical Pathology. 2022 Aug 1
- Join now to see all
Press Mentions
- Eureka Therapeutics Announces New England Journal of Medicine Publication of Clinical Study Demonstrating GPRC5D as an Active Target for the Treatment of Multiple MyelomaSeptember 28th, 2022
- Eureka Therapeutics Announces Publication of Crystal Structure of TCR Mimic Redirected T Cells Targeting Alpha-Fetoprotein (AFP) for Liver CancerAugust 3rd, 2022
- Eureka Therapeutics Announces Publication of Study Demonstrating Broad Anti-Tumor Activity of TCR Mimic-Redirected T Cells Targeting NDC80June 6th, 2022
- Join now to see all
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: